Figure 7.
Asphericity distributions calculated from SASA MD-simulations for linear oligoglucosamines 1a–6a (A), linear oligo-N-acetylglucosamines 1b–6b (B), cyclic oligoglucosamines 7a–12a (C) and cyclic oligo-N-acetylglucosamines 7b–12b (D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.